Description
Product Overview
Tirzepatide 30 mg is a laboratory-supplied research peptide provided in lyophilized powder form and manufactured to research-grade purity standards. Each vial is sealed to preserve compound integrity, stability, and consistency, supporting accurate handling and reproducible results within controlled laboratory research environments.
In non-clinical research settings, Tirzepatide is commonly referenced in experimental and analytical studies examining dual incretin receptor signaling models, peptide receptor interaction dynamics, and downstream molecular response mechanisms under defined in vitro conditions. As a synthetic peptide designed to interact with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor systems in research models, Tirzepatide features a well-characterised molecular structure suitable for use as a reference compound in peptide research, assay development, and exploratory laboratory investigations.
This product is supplied exclusively for laboratory research use. It is not approved for human or veterinary administration, medical treatment, or diagnostic purposes and must be handled only by qualified professionals in accordance with applicable laboratory regulations.
Research Background
Tirzepatide is a synthetic peptide widely referenced in preclinical and laboratory research literature focused on incretin-related signaling pathways, receptor binding behavior, and peptide-mediated molecular response models. In controlled, non-clinical research environments, Tirzepatide is utilised to investigate dual-receptor interaction dynamics, intracellular signaling cascades, and peptide stability characteristics in in vitro systems.
Due to its defined amino acid sequence and documented presence in experimental research, Tirzepatide is frequently included in laboratory studies examining peptide structure?function relationships and hormone-related signaling mechanisms under controlled conditions.
Research Characteristics (Non-Therapeutic)
- Referenced in incretin and receptor signaling research
- Suitable for controlled laboratory and in vitro investigations
- Lyophilized format supporting compound stability and consistency
- Defined molecular profile for reproducible analytical outcomes
- Intended for professional laboratory research use only
Product Specifications
- Compound: Tirzepatide
- Quantity: 30 mg per vial
- Form: Lyophilized powder
- Appearance: White to off-white solid
- Purity: Research-grade (see Certificate of Analysis where available)
- Packaging: Sealed laboratory research vial
Storage & Handling
Store the lyophilized compound at 8°C to maintain optimal stability. For long-term storage, freezing may be applied where appropriate. Protect from light, heat, and moisture. Once handled or prepared for research purposes, follow established laboratory protocols for storage, usage, and disposal in compliance with applicable regulations.
There are no reviews yet.